Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 11 studies | 30% ± 15% | |
| endothelial cell | 8 studies | 26% ± 9% | |
| astrocyte | 6 studies | 27% ± 8% | |
| glutamatergic neuron | 5 studies | 42% ± 12% | |
| neuron | 4 studies | 27% ± 7% | |
| granule cell | 4 studies | 18% ± 2% | |
| macrophage | 4 studies | 22% ± 4% | |
| epithelial cell | 4 studies | 24% ± 5% | |
| GABAergic neuron | 4 studies | 32% ± 12% | |
| endothelial cell of lymphatic vessel | 4 studies | 24% ± 7% | |
| fibroblast | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2541.11 | 2640 / 2642 | 100% | 27.44 | 703 / 705 |
| prostate | 100% | 1995.20 | 245 / 245 | 100% | 16.93 | 500 / 502 |
| esophagus | 100% | 2349.31 | 1445 / 1445 | 99% | 13.78 | 182 / 183 |
| breast | 100% | 3192.89 | 459 / 459 | 99% | 16.38 | 1105 / 1118 |
| skin | 100% | 2091.76 | 1808 / 1809 | 99% | 20.01 | 466 / 472 |
| ovary | 100% | 6537.92 | 180 / 180 | 98% | 17.64 | 423 / 430 |
| thymus | 100% | 2094.21 | 652 / 653 | 98% | 12.99 | 595 / 605 |
| intestine | 100% | 3532.92 | 966 / 966 | 98% | 10.71 | 514 / 527 |
| kidney | 100% | 1815.73 | 89 / 89 | 97% | 19.24 | 873 / 901 |
| stomach | 99% | 1953.72 | 357 / 359 | 97% | 12.62 | 277 / 286 |
| lung | 100% | 1860.46 | 576 / 578 | 97% | 11.36 | 1115 / 1155 |
| adrenal gland | 100% | 1620.64 | 257 / 258 | 96% | 17.64 | 221 / 230 |
| uterus | 100% | 2749.19 | 170 / 170 | 93% | 13.41 | 427 / 459 |
| pancreas | 95% | 844.81 | 312 / 328 | 97% | 11.59 | 172 / 178 |
| bladder | 100% | 2734.33 | 21 / 21 | 88% | 8.54 | 444 / 504 |
| liver | 100% | 1003.47 | 226 / 226 | 87% | 7.21 | 352 / 406 |
| adipose | 100% | 2904.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1328.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1993.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1014.76 | 792 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 1317.62 | 844 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 13.41 | 78 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 13.20 | 42 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 7.16 | 20 / 29 |
| peripheral blood | 47% | 487.90 | 436 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042474 | Biological process | middle ear morphogenesis |
| GO_0009952 | Biological process | anterior/posterior pattern specification |
| GO_0060023 | Biological process | soft palate development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | TSHZ1 |
| Protein name | Teashirt zinc finger homeobox 1 Teashirt homolog 1 (Antigen NY-CO-33) (Serologically defined colon cancer antigen 33) TSHZ1 protein |
| Synonyms | SDCCAG33 TSH1 |
| Description | FUNCTION: Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential). . |
| Accessions | ENST00000322038.5 [Q6ZSZ6-2] ENST00000560918.2 H0YN23 ENST00000580243.3 [Q6ZSZ6-1] ENST00000560661.1 A7YF73 Q6ZSZ6 H0YKA1 |
